May 30, 2023 — Twelve-month results from the SELUTION SFA trial have been presented for the first time at the Japan  Endovascular  Treatment (JET) Conference in Tokyo.

May 30, 2023 — Thirona, a global company specialized in advanced analysis of thoracic CT images with artificial intelligence, announces its new AI

May 26, 2023 — The Clinical Hospital of Emergency Services, a municipal hospital serving the community of Dnipro, in Ukraine, is the first in the country to take part in the American College of Cardiology’s 

May 25, 2023 — New data presented from an investigator-sponsored European trial found managing indicated1 heart failure patients with Abbott's CardioMEMS HF System resulted in a significant1 improvement in patient-reported quality-of-life scores as early as three months after u

May 26, 2023 — Atrial fibrillation, or AFib , is the most common heart rhythm problem, affecting millions of Americans and greatly increasing their risk of stroke and heart failure. For some with AFib, a catheter ablation is used to burn or freeze the precise area causing the problem to restore a normal heart rhythm.

May 25, 2023 — First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic stents, which are currently the standard treatment for heart disease patients undergoing percutaneous coronary intervention (PCI).  

May 25, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and cardiac rhythm management therapies, and the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device.

May 25, 2023 — Abbott announced late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device Exemption (IDE) study, a large-scale study to assess the world's first dual-chamber leadless pacemaker, showing that the leadless pacemaker met its three

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now